O
EXAS

OrbiMed’s Exact Sciences EXAS Stock Holding History

OrbiMed’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-351,716
Closed -$35.7M – 119
2025
Q4 		$35.7M Sell
351,716
-642,900
-65% -$51.6M 0.73% 42
2025
Q3 		$54.4M Buy
994,616
+387,300
+64% +$19.4M 1.28% 24
2025
Q2 		$32.3M Sell
607,316
-72,500
-11% -$3.68M 0.81% 31
2025
Q1 		$29.4M Hold
679,816
– – 0.7% 39
2024
Q4 		$38.2M Hold
679,816
– – 0.79% 36
2024
Q3 		$46.3M Buy
679,816
+7,400
+1% +$418K 0.84% 36
2024
Q2 		$28.4M Buy
672,416
+532,016
+379% +$29.3M 0.56% 49
2024
Q1 		$9.7M Buy
+140,400
New +$8.88M 0.18% 82
2017
Q2 		– Sell
-602,900
Closed -$14.2M – 145
2017
Q1 		$14.2M Sell
602,900
-347,100
-37% -$6.88M 0.16% 86
2016
Q4 		$12.7M Sell
950,000
-151,600
-14% -$2.45M 0.16% 80
2016
Q3 		$20.5M Sell
1,101,600
-1,029,600
-48% -$18.1M 0.23% 72
2016
Q2 		$26.1M Buy
2,131,200
+240,800
+13% +$1.81M 0.27% 67
2016
Q1 		$12.7M Buy
+1,890,400
New +$12.1M 0.13% 79
2015
Q4 		– Sell
-1,778,000
Closed -$32M – 132
2015
Q3 		$32M Hold
1,778,000
– – 0.32% 58
2015
Q2 		$52.9M Hold
1,778,000
– – 0.44% 52
2015
Q1 		$39.2M Hold
1,778,000
– – 0.33% 61
2014
Q4 		$48.8M Buy
1,778,000
+55,000
+3% +$1.34M 0.47% 51
2014
Q3 		$33.4M Hold
1,723,000
– – 0.35% 54
2014
Q2 		$29.3M Sell
1,723,000
-170,000
-9% -$2.34M 0.34% 54
2014
Q1 		$26.8M Sell
1,893,000
-3,096,300
-62% -$41.8M 0.33% 54
2013
Q4 		$58.6M Buy
4,989,300
+309,000
+7% +$3.54M 0.86% 35
2013
Q3 		$55.2M Sell
4,680,300
-21,600
-0.5% -$277K 0.99% 32
2013
Q2 		$65.4M Buy
+4,701,900
New +$51.1M 1.39% 28

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

OrbiMed's EXAS Position: Q1 2026 in Review

OrbiMed sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 351,716 shares — an estimated $35.7M sold.

OrbiMed first reported a position in EXAS in Q2 2013 and held it in 23 quarters. The position peaked at $65.4M in Q2 2013. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • OrbiMed reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • OrbiMed sold 351,716 Exact Sciences shares in Q1 2026, an estimated $35.7M.
  • OrbiMed first reported a position in Exact Sciences in Q2 2013 and held it in 23 quarters.
  • OrbiMed's Exact Sciences position peaked at $65.4M in Q2 2013.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on OrbiMed's 13F filing for Q1 2026, filed 15 May 2026.